500 attendees in Phoenix, Arizona to educate and inform the MG community. Myasthenia gravis is a rare neuromuscular, autoimmune disease that impacts more than 90,000 individuals in the United States ...

Significant variability in symptoms and disease burden exists among myasthenia gravis patients across MGFA classes, challenging the use of MGFA classification for individual prognosis. Many patients ...

MG Lexicon will help patients and medical professionals communicate and share common information concerning the rare autoimmune, neuromuscular disease myasthenia gravis BOSTON, Dec. 5, 2025 ...

MGFA aims to mitigate food insecurity and "food deserts" for the myasthenia gravis community through pre-prepared meals delivered to eligible MG families BOSTON, April 20, 2026 /PRNewswire/ -- ...

The Myasthenia Gravis Foundation of America (MGFA TM), the largest, leading patient advocacy organization solely dedicated to the myasthenia gravis (MG) community re-launched its MGFA Global MG ...

June is MG Awareness Month – Global campaigns focus on patient and caregiver inspiration, support and education, and community action to promote broader understanding of rare disease BOSTON, May 29, ...

Boston, MA, USA and Oxford, UK - 12 February 2026, Vitaccess, a leader in generating science-driven real-world evidence, has entered into an exclusive partnership with the Myasthenia Gravis Foundation ...

New data consistent with positive topline results showing rapid and clinically meaningful responses to efgartigimod and safety profile comparable to placebo Biologics License Application on track to ...

Andrea Divis was shocked to learn that her symptoms of fatigue, blurred vision, and muscle weakness were due to a rare condition called myasthenia gravis. Here’s how she educated herself and took back ...

The positions in the table below reflect the Myasthenia Gravis Foundation of America (MGFA)'s position overall, domestically, within their sector, and in various subject areas based on their Share.

The program is specifically designed to remove critical barriers to proper nutrition while helping myasthenia patients improve their daily quality of life, treatment adherence, and overall health.